Search Trials
For best results, use specific search terms. For example, instead of "brain tumor," try "glioblastoma." You can also contact the Clinical Trials Office at 312-695-1102 for assistance.
DRUG TP-CA-006: TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients with Head & Neck Squamous Cell Carcinoma (HNSCC)The purpose of this study is to understand the treatment journey for many patients with advanced head and neck squamous cell carcinoma (HNSCC) including looking at changes in genes and proteins associated with their cancer throughout the course of treatment. Part of this research may identify genetic changes in their tumor that are different from their normal genes. Note: This is only a partial description of the study. Please contact the Robert H. Lurie Comprehensive Cancer Center of Northwestern University if you are interested in the trial. Eligibility Criteria Some of the eligibility criteria include:
· Participants must have a diagnosis of advanced head and neck squamous cell carcinoma (HNSCC). · Participants must be 18 or older
Note: This is only a partial list of eligibility criteria. Please contact the Robert H. Lurie Comprehensive Cancer Center of Northwestern University for complete screening information if you are interested in this clinical trial.
Location(s) |